# Development of Clinical Database of Individuals With Smith-Magenis Syndrome and Sleep Disturbances

> **NCT03154697** · — · RECRUITING · sponsor: **Vanda Pharmaceuticals** · enrollment: 1000 (estimated)

## Conditions studied

- Sleep Disturbances in Smith-Magenis Syndrome

## Interventions

- **OTHER:** Data collection of sleep disturbances in individuals with SMS

## Key facts

- **NCT ID:** NCT03154697
- **Lead sponsor:** Vanda Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2016-01
- **Primary completion:** 2030-12
- **Final completion:** 2030-12
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2024-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03154697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03154697, "Development of Clinical Database of Individuals With Smith-Magenis Syndrome and Sleep Disturbances". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03154697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*